BCLx-gamma gene therapy (Boston Life Sciences)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug NameBCLx-gamma gene therapy (Boston Life Sciences)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionApoptosis regulator Bcl-X modulators
TargetsApoptosis regulator Bcl-X
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlseres Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlseres Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A